CONMED Corporation (CNMD)
USD 69.32
(-2.68%)
USD 69.32
(-2.68%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 643.06 Million USD | 12.57% |
| 2022 | 571.24 Million USD | 0.56% |
| 2021 | 568.03 Million USD | 23.41% |
| 2020 | 460.3 Million USD | -12.28% |
| 2019 | 524.71 Million USD | 11.85% |
| 2018 | 469.11 Million USD | 8.83% |
| 2017 | 431.04 Million USD | 5.56% |
| 2016 | 408.33 Million USD | 6.98% |
| 2015 | 381.7 Million USD | -4.21% |
| 2014 | 398.46 Million USD | -1.97% |
| 2013 | 406.46 Million USD | 0.15% |
| 2012 | 405.84 Million USD | 8.24% |
| 2011 | 374.93 Million USD | 2.61% |
| 2010 | 365.38 Million USD | 8.32% |
| 2009 | 337.33 Million USD | -11.78% |
| 2008 | 382.38 Million USD | 9.53% |
| 2007 | 349.12 Million USD | 11.6% |
| 2006 | 312.84 Million USD | -0.06% |
| 2005 | 313.02 Million USD | 9.11% |
| 2004 | 286.89 Million USD | 10.47% |
| 2003 | 259.69 Million USD | 9.5% |
| 2002 | 237.17 Million USD | 5.72% |
| 2001 | 224.34 Million USD | -3.92% |
| 2000 | 233.49 Million USD | 6.23% |
| 1999 | 219.8 Million USD | 15.44% |
| 1998 | 190.4 Million USD | 167.79% |
| 1997 | 71.1 Million USD | 6.76% |
| 1996 | 66.6 Million USD | 27.59% |
| 1995 | 52.2 Million USD | 44.2% |
| 1994 | 36.2 Million USD | 35.58% |
| 1993 | 26.7 Million USD | 19.73% |
| 1992 | 22.3 Million USD | 10.95% |
| 1991 | 20.1 Million USD | 24.84% |
| 1990 | 16.1 Million USD | 96.34% |
| 1989 | 8.2 Million USD | 22.39% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 161.97 Million USD | -12.13% |
| 2024 Q3 | 178.99 Million USD | 3.37% |
| 2024 Q2 | 173.15 Million USD | 6.9% |
| 2023 Q3 | 168.05 Million USD | -1.54% |
| 2023 Q4 | 184.32 Million USD | 9.68% |
| 2023 FY | 643.06 Million USD | 12.57% |
| 2023 Q2 | 170.69 Million USD | 9.89% |
| 2023 Q1 | 155.32 Million USD | 17.79% |
| 2022 Q3 | 151.61 Million USD | -0.11% |
| 2022 Q4 | 131.86 Million USD | -13.03% |
| 2022 Q1 | 135.99 Million USD | -12.75% |
| 2022 FY | 571.24 Million USD | 0.56% |
| 2022 Q2 | 151.77 Million USD | 11.61% |
| 2021 Q2 | 141.42 Million USD | 10.1% |
| 2021 Q1 | 128.44 Million USD | -5.21% |
| 2021 Q3 | 142.3 Million USD | 0.62% |
| 2021 Q4 | 155.85 Million USD | 9.52% |
| 2021 FY | 568.03 Million USD | 23.41% |
| 2020 Q4 | 135.51 Million USD | 1.36% |
| 2020 Q3 | 133.69 Million USD | 85.87% |
| 2020 Q2 | 71.92 Million USD | -39.64% |
| 2020 Q1 | 119.15 Million USD | -16.07% |
| 2020 FY | 460.3 Million USD | -12.28% |
| 2019 Q1 | 121.43 Million USD | -8.46% |
| 2019 FY | 524.71 Million USD | 11.85% |
| 2019 Q2 | 131.19 Million USD | 8.03% |
| 2019 Q3 | 130.11 Million USD | -0.82% |
| 2019 Q4 | 141.97 Million USD | 9.12% |
| 2018 FY | 469.11 Million USD | 8.83% |
| 2018 Q2 | 116.27 Million USD | 6.13% |
| 2018 Q1 | 109.55 Million USD | -11.62% |
| 2018 Q4 | 132.65 Million USD | 19.91% |
| 2018 Q3 | 110.62 Million USD | -4.85% |
| 2017 Q3 | 102.54 Million USD | -2.01% |
| 2017 Q1 | 99.88 Million USD | -6.61% |
| 2017 FY | 431.04 Million USD | 5.56% |
| 2017 Q4 | 123.95 Million USD | 20.88% |
| 2017 Q2 | 104.65 Million USD | 4.77% |
| 2016 FY | 408.33 Million USD | 6.98% |
| 2016 Q4 | 106.95 Million USD | 5.68% |
| 2016 Q1 | 97.74 Million USD | -4.53% |
| 2016 Q3 | 101.2 Million USD | -1.18% |
| 2016 Q2 | 102.42 Million USD | 4.79% |
| 2015 FY | 381.7 Million USD | -4.21% |
| 2015 Q3 | 93.54 Million USD | 0.05% |
| 2015 Q4 | 102.37 Million USD | 9.44% |
| 2015 Q2 | 93.49 Million USD | 1.32% |
| 2015 Q1 | 92.28 Million USD | -9.97% |
| 2014 Q1 | 101.23 Million USD | -7.85% |
| 2014 FY | 398.46 Million USD | -1.97% |
| 2014 Q3 | 95.08 Million USD | -4.59% |
| 2014 Q2 | 99.65 Million USD | -1.55% |
| 2014 Q4 | 102.49 Million USD | 7.8% |
| 2013 Q1 | 101.1 Million USD | -5.76% |
| 2013 FY | 406.46 Million USD | 0.15% |
| 2013 Q4 | 109.85 Million USD | 16.88% |
| 2013 Q3 | 93.99 Million USD | -7.4% |
| 2013 Q2 | 101.51 Million USD | 0.4% |
| 2012 FY | 405.84 Million USD | 8.24% |
| 2012 Q3 | 97.91 Million USD | -1.82% |
| 2012 Q2 | 99.73 Million USD | -1.17% |
| 2012 Q1 | 100.91 Million USD | 4.62% |
| 2012 Q4 | 107.28 Million USD | 9.57% |
| 2011 Q4 | 96.45 Million USD | 5.63% |
| 2011 FY | 374.93 Million USD | 2.61% |
| 2011 Q2 | 91.45 Million USD | -4.45% |
| 2011 Q3 | 91.31 Million USD | -0.16% |
| 2011 Q1 | 95.71 Million USD | 5.27% |
| 2010 Q2 | 93.68 Million USD | 2.06% |
| 2010 Q3 | 88.98 Million USD | -5.02% |
| 2010 Q4 | 90.92 Million USD | 2.18% |
| 2010 FY | 365.38 Million USD | 8.32% |
| 2010 Q1 | 91.79 Million USD | -4.41% |
| 2009 Q2 | 77.31 Million USD | 1.26% |
| 2009 FY | 337.33 Million USD | -11.78% |
| 2009 Q4 | 96.03 Million USD | 9.58% |
| 2009 Q3 | 87.63 Million USD | 13.35% |
| 2009 Q1 | 76.35 Million USD | -14.25% |
| 2008 Q4 | 89.03 Million USD | -5.97% |
| 2008 Q3 | 94.68 Million USD | -6.15% |
| 2008 Q2 | 100.89 Million USD | 3.2% |
| 2008 Q1 | 97.76 Million USD | 2.18% |
| 2008 FY | 382.38 Million USD | 9.53% |
| 2007 Q3 | 82.35 Million USD | -4.08% |
| 2007 Q2 | 85.86 Million USD | 0.75% |
| 2007 FY | 349.12 Million USD | 11.6% |
| 2007 Q4 | 95.68 Million USD | 16.18% |
| 2007 Q1 | 85.22 Million USD | 3.38% |
| 2006 Q4 | 82.44 Million USD | 10.32% |
| 2006 FY | 312.84 Million USD | -0.06% |
| 2006 Q3 | 74.73 Million USD | -3.91% |
| 2006 Q2 | 77.77 Million USD | -0.16% |
| 2006 Q1 | 77.9 Million USD | 4.61% |
| 2005 FY | 313.02 Million USD | 9.11% |
| 2005 Q4 | 74.46 Million USD | -1.96% |
| 2005 Q3 | 75.95 Million USD | -7.51% |
| 2005 Q2 | 82.12 Million USD | 2.05% |
| 2005 Q1 | 80.47 Million USD | 0.18% |
| 2004 Q1 | 70.35 Million USD | 0.98% |
| 2004 Q4 | 80.33 Million USD | 19.03% |
| 2004 Q2 | 68.71 Million USD | -2.34% |
| 2004 Q3 | 67.48 Million USD | -1.79% |
| 2004 FY | 286.89 Million USD | 10.47% |
| 2003 Q2 | 65.13 Million USD | 5.64% |
| 2003 Q4 | 69.67 Million USD | 10.2% |
| 2003 Q1 | 61.65 Million USD | 3.43% |
| 2003 FY | 259.69 Million USD | 9.5% |
| 2003 Q3 | 63.23 Million USD | -2.92% |
| 2002 FY | 237.17 Million USD | 5.72% |
| 2002 Q1 | 59.1 Million USD | -1.37% |
| 2002 Q2 | 59.55 Million USD | 0.77% |
| 2002 Q3 | 58.9 Million USD | -1.1% |
| 2002 Q4 | 59.6 Million USD | 1.2% |
| 2001 Q1 | 58.42 Million USD | -6.22% |
| 2001 FY | 224.34 Million USD | -3.92% |
| 2001 Q4 | 59.92 Million USD | 10.99% |
| 2001 Q3 | 53.98 Million USD | -0.41% |
| 2001 Q2 | 54.2 Million USD | -7.21% |
| 2000 FY | 233.49 Million USD | 6.23% |
| 2000 Q1 | 60.03 Million USD | 1.24% |
| 2000 Q2 | 56.47 Million USD | -5.93% |
| 2000 Q3 | 54.68 Million USD | -3.18% |
| 2000 Q4 | 62.29 Million USD | 13.93% |
| 1999 Q1 | 53.4 Million USD | 1.71% |
| 1999 Q2 | 54 Million USD | 1.12% |
| 1999 Q4 | 59.3 Million USD | 11.68% |
| 1999 Q3 | 53.1 Million USD | -1.67% |
| 1999 FY | 219.8 Million USD | 15.44% |
| 1998 Q3 | 50.6 Million USD | 10.48% |
| 1998 FY | 190.4 Million USD | 167.79% |
| 1998 Q2 | 45.8 Million USD | 10.63% |
| 1998 Q4 | 52.5 Million USD | 3.75% |
| 1998 Q1 | 41.4 Million USD | 116.75% |
| 1997 Q1 | 16.7 Million USD | -1.76% |
| 1997 Q3 | 19 Million USD | 17.28% |
| 1997 Q2 | 16.2 Million USD | -2.99% |
| 1997 Q4 | 19.1 Million USD | 0.53% |
| 1997 FY | 71.1 Million USD | 6.76% |
| 1996 Q3 | 17 Million USD | -0.58% |
| 1996 Q1 | 15.4 Million USD | 2.67% |
| 1996 Q4 | 17 Million USD | 0.0% |
| 1996 FY | 66.6 Million USD | 27.59% |
| 1996 Q2 | 17.1 Million USD | 11.04% |
| 1995 Q1 | 10 Million USD | 4.17% |
| 1995 Q4 | 15 Million USD | 13.64% |
| 1995 Q3 | 13.2 Million USD | -4.35% |
| 1995 FY | 52.2 Million USD | 44.2% |
| 1995 Q2 | 13.8 Million USD | 38.0% |
| 1994 Q1 | 8.9 Million USD | 2.3% |
| 1994 FY | 36.2 Million USD | 35.58% |
| 1994 Q4 | 9.6 Million USD | 6.67% |
| 1994 Q3 | 9 Million USD | 1.12% |
| 1994 Q2 | 8.9 Million USD | 0.0% |
| 1993 Q3 | 8 Million USD | 53.85% |
| 1993 Q4 | 8.7 Million USD | 8.75% |
| 1993 FY | 26.7 Million USD | 19.73% |
| 1993 Q1 | 5.5 Million USD | -3.51% |
| 1993 Q2 | 5.2 Million USD | -5.45% |
| 1992 Q2 | 5.9 Million USD | 7.27% |
| 1992 Q1 | 5.5 Million USD | -1.79% |
| 1992 FY | 22.3 Million USD | 10.95% |
| 1992 Q3 | 6.4 Million USD | 8.47% |
| 1992 Q4 | 5.7 Million USD | -10.94% |
| 1991 FY | 20.1 Million USD | 24.84% |
| 1991 Q1 | 4.5 Million USD | 12.5% |
| 1991 Q4 | 5.6 Million USD | 9.8% |
| 1991 Q3 | 5.1 Million USD | 2.0% |
| 1991 Q2 | 5 Million USD | 11.11% |
| 1990 Q2 | 4.2 Million USD | 7.69% |
| 1990 FY | 16.1 Million USD | 96.34% |
| 1990 Q4 | 4 Million USD | -2.44% |
| 1990 Q3 | 4.1 Million USD | -2.38% |
| 1990 Q1 | 3.9 Million USD | 62.5% |
| 1989 Q2 | 4.4 Million USD | 12.82% |
| 1989 Q4 | 2.4 Million USD | 26.32% |
| 1989 FY | 8.2 Million USD | 22.39% |
| 1989 Q1 | 3.9 Million USD | 8.33% |
| 1989 Q3 | 1.9 Million USD | -56.82% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott Laboratories | 22.13 Billion USD | 97.095% |
| Allurion Technologies Inc. | 41.49 Million USD | -1449.671% |
| Artivion, Inc. | 229.17 Million USD | -180.6% |
| Avanos Medical, Inc. | 379.7 Million USD | -69.362% |
| Butterfly Network, Inc. | 16.85 Million USD | -3715.063% |
| Butterfly Network, Inc. | 16.85 Million USD | -3715.063% |
| Bio-Rad Laboratories, Inc. | 1.43 Billion USD | 55.073% |
| Boston Scientific Corporation | 9.89 Billion USD | 93.501% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -39255.386% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | 86.096% |
| Paragon 28, Inc. | 172.79 Million USD | -272.165% |
| Glaukos Corporation | 239.13 Million USD | -168.913% |
| Globus Medical, Inc. | 1.02 Billion USD | 36.973% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | -21.742% |
| Integer Holdings Corporation | 418.28 Million USD | -53.737% |
| Medtronic plc | 19.45 Billion USD | 96.694% |
| Nevro Corp. | 290.06 Million USD | -121.701% |
| Owlet, Inc. | 22.58 Million USD | -2747.067% |
| Penumbra, Inc. | 682.64 Million USD | 5.797% |
| Vicarious Surgical Inc. | -1.85 Million USD | 34785.383% |
| Smith & Nephew plc | 3.7 Billion USD | 82.625% |
| Sonendo, Inc. | 10.72 Million USD | -5897.64% |
| STERIS plc | 2.23 Billion USD | 71.214% |
| Stryker Corporation | 13.05 Billion USD | 95.075% |
| Vapotherm, Inc. | 28.28 Million USD | -2173.687% |
| Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 87.89% |